The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes

Inherited defects of the neuromuscular junction (NMJ) comprise an increasingly diverse range of disorders, termed congenital myasthenic syndromes (CMS). Therapies acting on the sympathetic nervous system, including the selective β2 adrenergic agonist salbutamol and the α and β adrenergic agonist eph...

Descripción completa

Detalles Bibliográficos
Autores principales: McMacken, Grace, Cox, Dan, Roos, Andreas, Müller, Juliane, Whittaker, Roger, Lochmüller, Hanns
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905648/
https://www.ncbi.nlm.nih.gov/pubmed/29462491
http://dx.doi.org/10.1093/hmg/ddy062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905648/
https://www.ncbi.nlm.nih.gov/pubmed/29462491
http://dx.doi.org/10.1093/hmg/ddy062

Ejemplares similares